Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mensinga T
InChi: InChI=1S/C23H32O4/c1-14(24)23(27-15(2)25)12-9-20-18-6-5-16-13-17(26)7-10-21(16
Preischemic treatment with TRC160334 results in a pronounced induction of HSP70 in kidneys by 6 hours while postischemic treatment with TRC160334 results in a pronounced induction of HSP70 in kidneys by 12 hours as compared with the respective vehicle control
More important
1840(3):1194-1203
ABR-238901 Catalog No.:M17814-C Mensinga TABR 238901 is an orally active and potent S100A8 A9 blocker and inhibits S100A8 A9 interaction with its receptors RAGE (receptor for advanced glycation endproducts) and TLR4 (toll like receptor 4). ABR 238901 has the potential for myocardial infarction (MI) research. Product information CAS Number: 1638200 22 2 Molecular Weight: 394. 63 Formula: C11H9BrClN3O4S Chemical Name: 5 bromo N (5 chloro 4 hydroxypyridin 3 yl) 6 methoxypyridine 3 sulfonamide